Avalo Therapeutics
Executives
View the org chart displaying its 13 main executives
Most searched biographies at Avalo Therapeutics
- Garry Neil, Chairman of the Board and Chief Executive Officer
- Mitchell Chan, Director
- Magnus Persson, Lead Independent Director
Popular executive movements at Avalo Therapeutics
- Samantha Truex has joined the company as Independent Director (posted on April 3 2024).
- Jonathan Goldman has joined the company as Independent Director (posted on April 3 2024).
- Aaron Kantoff has joined the company as Director (posted on April 3 2024).
Create your alert
to follow the executive moves at Avalo Therapeutics.
Biotechnology
Avalo Therapeutics has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by Avalo Therapeutics
- Avalo Therapeutics Appoints Biotech Leaders to Board of Directors :: Avalo Therapeutics, Inc. (AVTX)
- Avalo Reports 2023 Financial Results and Provides Business Updates :: Avalo Therapeutics, Inc. (AVTX)
- Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million :: Avalo Therapeutics, Inc. (AVTX)
- Avalo Therapeutics Announces 1-for-240 Reverse Stock Split :: Avalo Therapeutics, Inc. (AVTX)
- Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split :: Avalo Therapeutics, Inc. (AVTX)
- Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates :: Avalo Therapeutics, Inc. (AVTX)
- Avalo Completes Divestiture of AVTX-800 Series :: Avalo Therapeutics, Inc. (AVTX)
- Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation :: Avalo Therapeutics, Inc. (AVTX)
- Avalo Enters into Agreement to Divest AVTX-800 Series :: Avalo Therapeutics, Inc. (AVTX)
- Avalo to Present at the H.C. Wainwright 25th Annual Global Investment Conference :: Avalo Therapeutics, Inc. (AVTX)
- View more press releases Close
Social media about Avalo Therapeutics
- Avalo Therapeutics on Wikipedia, Google News & Yahoo Finance
- Avalo Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Aaron Kantoff 
Call Avalo Therapeutics at +1 610...
